ArticleAmerican journal of epidemiology2026
Evaluating treatment benefit predictors using observational data: contending with identification and confounding bias.
Article in American journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
A treatment benefit predictor (TBP) is a function that maps patient characteristics to a putative treatment benefit for that patient. Such predictors support optimizing individualized treatment decisions, which are central to precision medicine. However, evaluating the predictive performance of a TBP is challenging, as this often must be conducted in a sample where treatment assignment is not random. After briefly reviewing several metrics for evaluating TBPs, we show conceptually how to evaluate a prespecified TBP using observational data from the target population, for a binary treatment decision at a single time point. We exemplify with a particular measure of discrimination (the concentration of benefit index) and a particular measure of calibration (the moderate calibration curve). The population-level definitions of these metrics involve the latent treatment benefit variable, but we show identification by re-expressing the respective estimands in terms of the distribution of observable data only. We also show that in the absence of full confounding control, bias propagates in a more complex manner than when targeting more commonly encountered estimands. We find the patterns of biases are often unpredictable, and general intuition about the direction of bias in causal effect estimates does not hold in the present context.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.